Tietueen sitaatit

APA-viite (7. p.)
Henry O. Herrera, B., Carol Sanchez, M., Gabrielle Minor, P., & Gregory J. Fulchiero, J., MD. (2026). Successful treatment of cutaneous sarcoidosis with deucravacitinib, a selective TYK2 inhibitor. Elsevier.
Chicago-viite (17. p.)
Henry O. Herrera, BS, MD Carol Sanchez, PA-C Gabrielle Minor, ja Jr. Gregory J. Fulchiero, MD. Successful Treatment of Cutaneous Sarcoidosis with Deucravacitinib, a Selective TYK2 Inhibitor. Elsevier, 2026.
MLA-viite (9. p.)
Henry O. Herrera, BS, et al. Successful Treatment of Cutaneous Sarcoidosis with Deucravacitinib, a Selective TYK2 Inhibitor. Elsevier, 2026.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.